Elisabeth Leiderman
2021
In 2021, Elisabeth Leiderman earned a total compensation of $569.9K as Former Chief Financial Officer and Head of Corporate Development at Decibel Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Salary | $397,308 |
| Other | $12,590 |
| Total | $569,898 |
Leiderman received $397.3K in salary, accounting for 70% of the total pay in 2021.
Leiderman also received $160K in non-equity incentive plan and $12.6K in other compensation.
Rankings
In 2021, Elisabeth Leiderman's compensation ranked 10,437th out of 12,415 executives tracked by ExecPay. In other words, Leiderman earned more than 15.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,437 out of 12,415 | 16th |
Division Manufacturing | 4,620 out of 5,505 | 16th |
Major group Chemicals And Allied Products | 2,070 out of 2,375 | 13th |
Industry group Drugs | 1,836 out of 2,096 | 12th |
Industry Pharmaceutical Preparations | 1,362 out of 1,546 | 12th |
Source: SEC filing on April 28, 2023.
Leiderman's colleagues
We found three more compensation records of executives who worked with Elisabeth Leiderman at Decibel Therapeutics in 2021.